[ 1 ] Lo KW, To KF, Huang DP. Focus on nasopharyngeal carcinoma[J]. Cancer Cell, 2004, 5(5): 423-428.
[2]
[ 2 ] Hui EP, Leung SF, Au JS, et al. Lung metastasis alone in nasopharyngeal carcinoma: a relatively favorable prognostic group. A study by the Hong Kong Nasopharyngeal Carcinoma Study Group[J]. Cancer, 2004, 101(2): 300-306.
[3]
[ 3 ] Al-Sarraf M, LeBlanc M, Giri PG, et al. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase Ⅲ randomized Intergroup study 0099[J]. J Clin Oncol, 1998, 16(4): 1310-1317.
[4]
[ 4 ] Pfrister DG, Aug K, Brizel DM, et al. NCCN clinical practice guidelines in oncology: head and neck cancers[J]. JNCCN, 2011, 11(9): 596-650.
[5]
[ 5 ] Wakisaka N, Wen QH, Yoshizaki T, et al. Association of vascular endothelial growth factor expression with angiogenesis and lymph node metastasis in nasopharyngeal carcinoma[J]. Laryngoscope, 1999, 109(5): 810-814.
[6]
[ 6 ] Kong HL, Crystal RG. Gene therapy strategies for tumor antiangiogenesis[J]. J Natl Cancer Inst, 1998, 90(4): 273-286.
[7]
[ 7 ] Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic Switch during tumorigenesis[J]. Cell, 1996, 86(3): 353-364.
[8]
[ 8 ] Ben-Baruch A. Organ selectivity in metastasis: regulation by chemokines and their receptors[J]. Clin Exp Metastasis, 2008, 25(4): 345-356.
[9]
[ 9 ] Kato M, Kitayama J, Kazama S, et al. Expression pattern of CXC chemokine receptor-4 is correlated with lymph node metastasis in human invasive ductal carcinoma[J]. Breast Cancer Res, 2003, 5(5): R144-R150.
[10]
Liang Z, Yoon Y, Votaw J, et al. Silencing of CXCR4 blocks breast cancer metastasis[J]. Cancer Res, 2005, 65(3): 967-971.
Brand S, Dambacher J, Beigel F, et al. CXCR4 and CXCL12 are inversely expressed in colorectal cancer cells and modulate cancer cell migration, invasion and MMP-9 activation[J]. Exp Cell Res, 2005, 310(1): 117-130.
[13]
Mattern J, Koom？gi R, Volm M. Biological characterization of subgroups of squamous cell lung carcinomas[J]. Clin Cancer Res, 1999, 5(6): 1459-1463.
[14]
Weidner N. Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors[J]. Breast Cancer Res Treat, 1995, 36(2): 169-180.
[15]
Pan J, Kong L, Lin S, et al. The clinical significance of coexpression of cyclooxygenases-2, vascular endothelial growth factors, and epidermal growth factor receptor in nasopharyngeal carcinoma[J]. Laryngoscope, 2008, 118(11): 1970-1975.
[16]
Segawa Y, Oda Y, Yamamoto H, et al. Close correlation between CXCR4 and VEGF expression and their prognostic implications in nasopharyngeal carcinoma[J]. Oncol Rep, 2009, 21(5): 1197-1202.
[17]
Chan CM, Ma BB, Hui EP, et al. Cyclooxygenase-2 expression in advanced nasopharyngeal carcinoma--a prognostic evaluation and correlation with hypoxia inducible factor 1alpha and vascular endothelial growth factor[J]. Oral Oncol, 2007, 43(4): 373-378.
[18]
Hui EP, Chan AT, Pezzella F, et al. Coexpression of hypoxia-inducible factors 1alpha and 2alpha, carbonic anhydraseⅨ, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival[J]. Clin Cancer Res, 2002, 8(8): 2595-2604.
[19]
Kim TJ, Lee YS, Kang JH, et al. Prognostic significance of expression of VEGF and Cox-2 in nasopharyngeal carcinoma and its association with expression of C-erbB2 and EGFR[J]. J Surg Oncol, 2011, 103(1): 46-52.
[20]
Folkman J. What is the evidence that tumors are angiogenesis dependent[J]. J Natl Cancer Inst, 1990, 82(1): 4-6.
Ogawa Y, Chung YS, Nakata B, et al. Microvessel quantitation in invasive breast cancer by staining for factorⅧ-related antigen[J]. Br J Cancer, 1995, 71(6): 1297-1301.
[23]
Rubio L, Burgos JS, Morera C, et al. Morphometric study of tumor angiogenesis as a new prognostic factor in nasopharyngeal carcinoma patients[J]. Pathol Oncol Res, 2000, 6(3): 210-216.
[24]
Wang N, Wu QL, Fang Y, et al. Expression of chemokine receptor CXCR4 in nasopharyngeal carcinoma: pattern of expression and correlation with clinical outcome[J]. J Transl Med, 2005(3): 26.
[25]
Murakami T, Maki W, Cardones AR, et al. Expression of CXC chemokine receptor-4 enhances the pulmonary metastatic potential of murine B16 melanoma cells[J]. Cancer Res, 2002, 62(24): 7328-7334.
[26]
Kang Y, Siegel PM, Shu W, et al. A multigenic program mediating breast cancer metastasis to bone[J]. Cancer Cell, 2003, 3(6): 537-549.
